Over 4000 free audio and video lectures, seminars and teaching resources from Oxford University.
Skip to Content Skip to Navigation

drugs

# Episode Title Description People Date
1 A War on People: The Drug War and the Hermeneutic Politics of Those who Resist it This Anthropology Departmental Seminar was given by Jarrett Zignon (University of Amsterdam) on 2 December 2016. Jarrett Zignon 31 Jul 2017
2 Drug and Target Discovery in Parkinson's Disease Prof. Richard Wade-Martins discusses how you pick promising new drugs targets for Parkinson's Richard Wade-Martins 05 Jul 2016
3 Creative Commons Research, Policy, and Societal Perspectives on New Psychoactive Substances Part four of the 'Interventional Perspectives on Substance Use and Misuse' seminar series which took place in Hilary Term 2014. Harry Sumnall 19 May 2015
4 Creative Commons Adolescent Substance Use: What Do We Think We Know, Should We Intervene and if so, When? Part two of the 'Interventional Perspectives on Substance Use and Misuse' seminar series which took place in Hilary Term 2014. Alex Sutherland 19 May 2015
5 Creative Commons Drug Control, Human Rights and Bridging 'Parallel Universes' Part one of the 'Interventional Perspectives on Substance Use and Misuse' seminar series which took place in Hilary Term 2014. Rick Lines 19 May 2015
6 Creative Commons Why do we need to reconstruct drug discovery? Dr Javier Lezaun and Professor Chas Bountra give a talk about drug discovery. Chas Bountra, Javier Lezaun 17 Feb 2015
7 Part 4: A New Age of Drug Discovery You just have to step into your local chemist to see how far medicine has come over the past 100 years. Life changing drugs, which were once unthinkable – like antibiotics, insulin and the contraceptive pill – are now commonplace. Jonathan Webb 05 Nov 2014
8 Why is Oxford Determined to Change the Way We Discover New Medicines? Chas Bountra, a popular speaker at the recent Meeting Minds: Alumni Weekend in Asia, will explain how Oxford is creating a new ecosystem for drug discovery. Chas Bountra 07 Oct 2014
9 Deadly Devices and Dangerous Drugs, the Secrets Behind Medical Research A talk hosted by Kellogg College and the Centre for Evidence-Based Medicine at the University Museum of Natural History, as part of the University's Alumni Weekend. Carl Heneghan, Jeff Aronson, Deb Cohen, Ben Goldacre 03 Oct 2014
10 Big Data and Drug Discovery (The Osler Discussion) 'Big data' in medicine is an emerging field with the potential to revolutionise healthcare research.This session will look at how Oxford is addressing some of these research opportunities and challenges. Martin Landray 04 Oct 2013
11 3D Printing and The Structure of Proteins Using 3D printed molecules, Rok Sekirnik, a DPhil student in the emerging field of chemical biology, shows how protein structures can be determined in some of the Department's most distinctive looking labs. Rok Sekirnik 19 Jul 2013
12 Creative Commons OxPeace 2013: Illicitily Governed Spaces: drugs, conflict and peace in Columbia Session 1A: Counter-Terrorism and Peacebuilding Annette Idler, gives a talk for the OxPeace 2013 conference: The Future of Peace Building. Annette Idler 21 May 2013
13 How can we get the media to tell the truth about drugs? Professor David Nutt (Imperial College London) delivers the 2011 Monica Fooks Memorial Lecture. David Nutt 07 Dec 2011
14 Creative Commons Bio-Ethics Bites Demand for health care is infinite, but money is finite. So how should we distribute resources? Whom should we help, and why? Jonathan Wolf 03 Oct 2011
15 Oxford at Said Seminar: Drug Discovery In this seminar two academics explore experimental medicine in early-phase clinical trials and reforming intellectual property. Vincenzo Libri, Chas Bountra 04 Jul 2011
16 Medical Innovation 2010: Parallel Session 8 Financing Innovation: How can we utilise novel mechanisms to fund innovation? Rob James, Shelagh Wilson, Javier Guzman, Adrian Towse 02 Aug 2010
17 Medical Innovation 2010: Parallel Session 7 Evaluating Innovation: How do we evaluate innovation appropriately? Stephen Richards, Kalipso Chalkidou, Robyn Norton, Paul Glasziou 02 Aug 2010
18 Medical Innovation 2010: Parallel Session 6 Clinical Entrepreneurship. Oliver Bernath, Jake Arnold-Forster, Richard Darch, Mike Stein 02 Aug 2010
19 Medical Innovation 2010: Parallel Session 5 Entrepreneurship in the Community. Pamela Hartigan, Joop Tanis, Andrea Coleman, Deborah Szebeko 02 Aug 2010
20 Medical Innovation 2010: Parallel Session 4 Change and Innovation: What are the obstacles to change in complex health organisations in the UK? Sue Dopson, Keith Ruddle, Andrew Pettigrew, Allan Cole 02 Aug 2010
21 Medical Innovation 2010: Parallel Session 2 Healthcare Service Innovations: How do we provide high quality healthcare with decreased resources globally? Steve Fairman, Keith Willet, Thulsi Ravilla, Peter McCulloch 02 Aug 2010
22 Medical Innovation 2010: Parallel Session 1 Innovation to Practice: What are the challanges to bringing innovative drugs and devices into healthcare delivery and practice globally? Lionel Tarassenko, Constantin Coussios, Peter Dobson, Christopher Elias 02 Aug 2010
23 Medical Innovation 2010: Opening Remarks and Keynote Address Opening remarks for the Medical Innovation 2010 Conference and a Keynote Address given by Prof Baron Peter Piot, The Institute for Global Health, Imperial College London, 'Harnessing Innovation to Meet the Challenges of a Changing Global Health Landscape' Sue Dopson, Andrew Hamilton, Peter Piot 02 Aug 2010
24 Why it doesn't matter whether we're at war with al-Qaeda Anthony Dworkin (European Council on Foreign Relations) gives a talk for the Centre for Ethics, Law and Armed Conflict seminar series. Anthony Dworkin 14 Jun 2010
25 The Mafia and the Mullah: Counternarcotics, Counterinsurgency and Realpolitik in Afghanistan Captain William Park (U.S. Navy Hudson Fellow, CCW Visiting Fellow and ELAC Research Associate) gives a talk for the Centre for Ethics, Law and Armed Conflict seminar series. William Park 14 Jun 2010
26 Is there a healthy future for Big Pharma? Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. John Patterson, Sophia Tickell 04 Feb 2010
27 Is there a healthy future for Big Pharma? Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. John Patterson, Sophia Tickell 04 Feb 2010
28 A Pharma perspective on healthcare needs and innovation in drug discovery The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. Patrick Vallance, Philip Bloomer 09 Jun 2009
29 A Pharma perspective on healthcare needs and innovation in drug discovery The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. Patrick Vallance, Philip Bloomer 09 Jun 2009
30 Pharmaceutical Companies, Government and Society This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment. Sir Michael Rawlins 04 Jun 2009
31 Pharmaceutical Companies, Government and Society This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment. Sir Michael Rawlins 04 Jun 2009
32 Pharmaceutical Industry: Origin and Evolution Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. Tilli Tansey 19 May 2009
33 Pharmaceutical Industry: Origin and Evolution Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. Tilli Tansey 19 May 2009
34 Computer Aided Drug Design Prof. Graham Richards lectures at the Sutton Trust Chemistry Summer School, a week long workshop featuring chemistry lectures and lab work. Graham Richards 24 Apr 2008